Investigating influenza A virus infection: Tools to track infection and limit tropism

Journal of Virology

Volumn 89, Issue 12, 2015, Pages 6167-6170

  Fiege, Jessica K ^a   Langlois, Ryan A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; LIVE VACCINE; MICRORNA; NONSTRUCTURAL PROTEIN 1;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CELL FATE; CELL TRACKING; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; TREATMENT RESPONSE; TROPISM; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; INFLUENZA A VIRUS; MOLECULAR BIOLOGY; PHYSIOLOGY; PROCEDURES; REPORTER GENE; VIRAL TROPISM; VIROLOGY;

INFLUENZA A VIRUS; MAMMALIA;

ANIMALS; GENES, REPORTER; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; MOLECULAR BIOLOGY; VIRAL TROPISM; VIROLOGY;

EID: 84929593665     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00462-15     Document Type: Article

References (20)

1. Endo Y, Carroll KN, Ikizler MR, Wright PF. 1996. Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol 70:2055-2058.
2. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 101:4620-4624. http://dx.doi.org/10.1073/pnas.0308001101.
3. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B, Greer P, Jones T, Smith C, Bartlett J, Montague J, White E, Rollin D, Gao R, Seales C, Jost H, Metcalfe M, Goldsmith CS, Humphrey C, Schmitz A, Drew C, Paddock C, Uyeki TM, Zaki SR. 2010. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177:166-175. http://dx.doi.org/10.2353/ajpath.2010.100115.
4. Smed-Sörensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, Nakamura N, Delamarre L, Mellman I. 2012. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog 8:e1002572. http://dx.doi.org/10.1371/journal.ppat.1002572.
5. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA 107: 11531-11536. http://dx.doi.org/10.1073/pnas.0914994107.
6. Heaton NS, Langlois RA, Sachs D, Lim JK, Palese P, tenOever BR. 2014. Long-term survival of influenza virus infected club cells drives immunopathology. J Exp Med 211:1707-1714. http://dx.doi.org/10.1084/jem.20140488.
7. Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P. 2013. In vivo bioluminescent imaging of influenza A virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol 87: 8272-8281. http://dx.doi.org/10.1128/JVI.00969-13.
8. Tran V, Moser LA, Poole DS, Mehle A. 2013. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol 87:13321-13329. http://dx.doi.org/10.1128/JVI.02381-13.
9. Karlsson EA, Meliopoulos VA, Savage C, Livingston B, Mehle A, Schultz-Cherry S. 2015. Visualizing real-time influenza virus infection, transmission and protection in ferrets. NatCommun 6:6378. http://dx.doi.org/10.1038/ncomms7378.
10. Pan W, Dong Z, Li F, Meng W, Feng L, Niu X, Li C, Luo Q, Li Z, Sun C, Chen L. 2013. Visualizing influenza virus infection in living mice. Nat Commun 4:2369. http://dx.doi.org/10.1038/ncomms3369.
11. Eckert N, Wrensch F, Gartner S, Palanisamy N, Goedecke U, Jager N, Pohlmann S, Winkler M. 2014. Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins. PLoS One 9:e97695. http://dx.doi.org/10.1371/journal.pone.0097695.
12. Pena L, Sutton T, Chockalingam A, Kumar S, Angel M, Shao H, Chen H, Li W, Perez DR. 2013. Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol 87:5118-5127. http://dx.doi.org/10.1128/JVI.02490-12.
13. Sutton TC, Obadan A, Lavigne J, Chen H, Li W, Perez DR. 2014. Genome rearrangement of influenza virus for anti-viral drug screening. Virus Res 189:14-23. http://dx.doi.org/10.1016/j.virusres.2014.05.003.
14. Fukuyama S, Katsura H, Zhao D, Ozawa M, Ando T, Shoemaker JE, Ishikawa I, Yamada S, Neumann G, Watanabe S, Kitano H, Kawaoka Y. 2015. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies. Nat Commun 6:6600. http://dx.doi.org/10.1038/ncomms7600.
15. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. 2008. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4:239-248. http://dx.doi.org/10.1016/j.chom.2008.08.003.
16. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, tenOever BR. 2009. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol 27:572-576. http://dx.doi.org/10.1038/nbt.1542.
17. Langlois RA, Varble A, Chua MA, Garcia-Sastre A, tenOever BR. 2012. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc Natl Acad Sci USA 109:12117-12122. http://dx.doi.org/10.1073/pnas.1206039109.
18. Duprex WP, Casadevall A. 2014. Falling down the rabbit hole: aTRIP toward lexiconic precision in the "gain-of-function" debate. mBio 5:e02421-14. http://dx.doi.org/10.1128/mBio.02421-14.
19. Langlois RA, Albrecht RA, Kimble B, Sutton T, Shapiro JS, Finch C, Angel M, Chua MA, Gonzalez-Reiche AS, Xu K, Perez D, Garcia-Sastre A, tenOever BR. 2013. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nature Biotechnology 31:844-847. http://dx.doi.org/10.1038/nbt.2666.
20. Varble A, Albrecht RA, Backes S, Crumiller M, Bouvier NM, Sachs D, Garcia-Sastre A, tenOever BR. 2014. Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell Host Microbe 16:691-700. http://dx.doi.org/10.1016/j.chom.2014.09.020.